AI in Healthcare: Regulatory Perspectives and Prognoses

by Theodore Thompson | at Minnebar 18 | 2:50 – 3:35 in Proverb-Edison | View Schedule

Healthcare is already heavily regulated. AI technology presents some additional concerns for health-tech companies, and new regulations seek to add to the regulatory burden. This presentation is for companies working with FDA and EU regulators on brining their health-tech products to market.


Theodore Thompson

With over a decade's worth of experience working at the world's largest medical device company and years practicing at a boutique FDA law firm, Theo brings a comprehensive perspective to addressing client needs with efficiency and thoroughness. His dedication lies in empowering clients to achieve success, enabling them to concentrate on their primary goal of aiding patients and keeping their products compliant.

He helps clients bridge the gap between FDA requirements and industry knowledge. Both in-house and in private practice, Theo has been a trusted advisor providing guidance on intricate matters including medical device reporting, 510(k) submissions, Pre-Market Approval (PMA), Investigational Device Exemptions (IDE), clinical trial agreements, data privacy, cybersecurity practices, and more.

Similar Sessions

Does this session sound interesting? You may also like these: